Akanda Has Regained Compliance With Nasdaq's Minimum Bid Price Requirement

Akanda Has Regained Compliance With Nasdaq's Minimum Bid Price Requirement

newsfile ·  06/13 02:30

London, United Kingdom--(Newsfile Corp. - June 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has received a letter (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated June 7, 2024, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").

英國倫敦-(新聞宣傳社-2024年6月12日)-Akanda Corp.(NASDAQ:AKAN)("Akanda"或"公司")是一家國際醫用大麻公司,今天宣佈收到一封來自納斯達克股票市場公司("納斯達克")上市資格部門的信("合規通知"),日期爲2024年6月7日,通知公司已符合納斯達克上市規則5550(a)(2)("最低買入要求")的要求。

As previously announced, Akanda received a notification letter from Nasdaq dated July 3, 2023 indicating that its common shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of Nasdaq. According to the Compliance Notice, since then, Nasdaq has determined that for 10 consecutive business days, from May 23, 2024 to June 6, 2024, the closing bid price of the Company's common shares has been at $1.00 per share or greater, and accordingly the Company has regained compliance with the Minimum Bid Price Requirement and the matter is closed.


About Akanda Corp.

關於Akanda corp。

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.

Akanda是一家國際醫用大麻和健康平台公司,旨在通過改善高品質和價格實惠產品的獲得,幫助人們過上更好的生活。Akanda的投資組合包括CanMart,是總部位於英國的全牌照藥品進口商和經銷商,向英國內的藥店和診所提供產品。該公司的種子患者供應鏈還包括與Cellen Life Sciences' Leva Clinic 的合作關係,後者是英國首批全數字化疼痛診所之一。Akanda還獲得了在不列顛哥倫比亞省開發農場和相關經營和許可的權利。公司計劃在該地點開發THC和大麻二酚(CBD)設施。

Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram

與Akanda聯繫: 電子郵件 | 網站 | 領英 | 推特 | Instagram

Investor Contact


Cautionary Note Regarding Forward-Looking Information and Statements


This press release contains certain "forward-looking information" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved" and similar expressions and include statements regarding the timing and completion of the proposed offering. Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.